ArticleMolecular and clinical oncology2025

SMC2 as a potential prognostic biomarker in lung adenocarcinoma and its correlation with immune microenvironment.

Fuqiang Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.